Phase 1/2 trial evaluating the proprietary combination to be run under CRADA with the National Cancer InstituteSecondVersamune®platform candidate ...

PDS Biotechnology (PDSB) announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application filed in ...

PDS Biotechnology has commenced the randomised, multi-centre Phase III clinical trial, VERSATILE-003, to assess the efficacy ...

Rapidly developing technology is constantly being harnessed by Proximity Detection Systems (PDS) to deliver steadily improved ...

PDS Health™, a leading integrated healthcare support organization, proudly joins the American Dental Assistants Association ...

PDS announced that PDS Multinational FZCO., a wholly-owned step-down subsidiary of the company in the United Arab Emirates (UAE), has today, i.e., 06 March 2025, notified the Company's officer about ...